Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis in a Single Patient.
Adult
Antitubercular Agents
/ pharmacology
Bacterial Typing Techniques
Drug Resistance, Multiple, Bacterial
/ drug effects
Drug Therapy, Combination
Genes, Bacterial
Humans
Male
Microbial Sensitivity Tests
Mycobacterium tuberculosis
/ drug effects
Treatment Outcome
Tuberculosis, Multidrug-Resistant
/ diagnosis
Mycobacterium tuberculosis
bacteria
drug resistance
heteroresistance
spoligotyping
tuberculosis and other mycobacteria
whole genome sequencing
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
pubmed:
28
8
2019
medline:
9
4
2020
entrez:
28
8
2019
Statut:
ppublish
Résumé
A patient who had initial infection with mixed strains of drug-susceptible and multidrug-resistant tuberculosis was presumed to have acquired drug resistance before confirmation that sequential strains were genotypically distinct. Transmitted infection with mixed strains is likely underappreciated; identifying these infections requires spoligotyping and whole-genome sequencing.
Identifiants
pubmed: 31454310
doi: 10.3201/eid2511.180638
pmc: PMC6810186
doi:
Substances chimiques
Antitubercular Agents
0
Types de publication
Case Reports
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
2120-2121Références
J Clin Microbiol. 2014 Jun;52(6):1932-7
pubmed: 24648563
N Engl J Med. 2017 Jan 19;376(3):243-253
pubmed: 28099825
Emerg Infect Dis. 2000 Sep-Oct;6(5):548-51
pubmed: 10998389
Int J Infect Dis. 2017 Mar;56:130-135
pubmed: 27986491
Antimicrob Agents Chemother. 2011 May;55(5):2032-41
pubmed: 21300839
Emerg Infect Dis. 2013 Jul;19(7):1138-41
pubmed: 23764343
Tuberculosis (Edinb). 2010 May;90(3):201-7
pubmed: 20435520
Emerg Infect Dis. 2009 Apr;15(4):578-80
pubmed: 19331736
Lancet. 1995 Jun 10;345(8963):1512
pubmed: 7769926
PLoS One. 2017 May 18;12(5):e0176522
pubmed: 28545050